Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity
Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity
Recruiting · NCT07785934 · Registry updated 2026-08-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 | 2026-08-25 | NCT07785934 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The United Bio-Technology (Hengqin) Co., Ltd. | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Second Hospital of Anhui Medical University | Hefei | China | 1 |